LAB
Standard Biotools IncKey Statistics
About Standard Biotools Inc
Standard Biotools Inc. (LAB) is a pioneering biotechnology company dedicated to enhancing genomic analysis and biological research through cutting-edge tools and technologies. The firm specializes in developing high-performance products that cater specifically to laboratories engaged in genomics and proteomics, thereby significantly improving research precision and operational efficiency. By employing proprietary platforms, Standard Biotools enables researchers to expedite discoveries and elevate the standard of their scientific endeavors. Positioned strategically within the rapidly evolving biotechnology sector, LAB is well-equipped to address the growing need for advanced analytical solutions that are essential to the life sciences industry.
Fundamentals
| Revenue (TTM) | $85.33M |
| Gross Profit (TTM) | $42.54M |
| EBITDA | $-82.33M |
| Operating Margin | -92.10% |
| Return on Equity | -13.10% |
| Return on Assets | -9.88% |
| Revenue/Share (TTM) | $0.22 |
| Book Value | $1.10 |
| Price-to-Book | 0.83 |
| Price-to-Sales (TTM) | 4.22 |
| EV/Revenue | 2.27 |
| EV/EBITDA | -19.22 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -4.00% |
| Shares Outstanding | $390.37M |
| Float | $216.47M |
| % Insiders | 2.98% |
| % Institutions | 77.25% |
Historical Volatility
Volatility is currently contracting